HS-10345 84mg
HS-10345-102
Phase 1 small_molecule completed
Quick answer
HS-10345 84mg for Treatment Resistant Depressive Disorder is a Phase 1 program (small_molecule) at Jian Li with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jian Li
- Indication
- Treatment Resistant Depressive Disorder
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed